Detalles de la búsqueda
1.
Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial.
Lancet Infect Dis
; 23(2): 183-195, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36272432
2.
Characterisation of SARS-CoV-2 genomic variation in response to molnupiravir treatment in the AGILE Phase IIa clinical trial.
Nat Commun
; 13(1): 7284, 2022 11 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-36435798
3.
Public Engagement with Science via Social Media: A Case of Communicating the Pandemic on Twitter.
Proc Assoc Inf Sci Technol
; 58(1): 759-761, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34901401
4.
Specific language impairment and school outcomes. II: Educational context, student satisfaction, and post-compulsory progress.
Int J Lang Commun Disord
; 44(1): 36-55, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-18608602
5.
Specific language impairment and school outcomes. I: identifying and explaining variability at the end of compulsory education.
Int J Lang Commun Disord
; 44(1): 15-35, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-18608604
6.
The benefit of minocycline on negative symptoms of schizophrenia in patients with recent-onset psychosis (BeneMin): a randomised, double-blind, placebo-controlled trial.
Lancet Psychiatry
; 5(11): 885-894, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30322824
7.
Bullying risks of 11-year-old children with specific language impairment (SLI): does school placement matter?
Int J Lang Commun Disord
; 38(1): 1-12, 2003.
Artículo
en Inglés
| MEDLINE | ID: mdl-12569033
8.
Different school placements following language unit attendance: which factors affect language outcome?
Int J Lang Commun Disord
; 37(2): 185-95, 2002.
Artículo
en Inglés
| MEDLINE | ID: mdl-12012615
Resultados
1 -
8
de 8
1
Próxima >
>>